Search

Search results

893 results found

Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

Hutton, David, Joshua Stein, Adam Glassman, Neil Bressler, Lee Jampol, Jennifer Sun, and DRCR Retina Network. 2019. “Five-Year Cost-Effectiveness of Intravitreous Ranibizumab Therapy Vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial”. JAMA Ophthalmol, 1-9.